Host immunity to Cryptococcus neoformans

Soma Rohatgi1, Liise-Anne Pirofski

  • 1Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Future Microbiology
|April 14, 2015
PubMed

Insights

Cryptococcosis, a fungal infection, primarily affects HIV patients but also impacts transplant recipients and those with immunodeficiencies. This review details immune responses to Cryptococcus neoformans, highlighting B cells and natural IgM.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Cryptococcosis is a serious fungal infection caused by the genus Cryptococcus.
  • It predominantly manifests as meningoencephalitis, particularly in individuals with HIV and T-cell deficiency.
  • While combination antiretroviral therapy has reduced incidence in HIV patients, cryptococcosis remains a threat in resource-limited settings and affects other immunocompromised individuals.

Purpose of the Study:

  • To review the innate and adaptive immune responses to Cryptococcus neoformans.
  • To emphasize recent findings on the role of specific immune components in resistance to cryptococcosis.

Main Methods:

  • Literature review of studies on Cryptococcus neoformans.
  • Focus on research investigating B cell function.
  • Analysis of the impact of natural IgM and Fc gamma receptor polymorphisms.

Main Results:

  • Innate and adaptive immunity play crucial roles in controlling Cryptococcus neoformans.
  • Recent studies highlight the significance of B cells in antifungal defense.
  • Natural IgM and Fc gamma receptor polymorphisms are associated with varying levels of resistance.

Conclusions:

  • Understanding immune responses is key to combating cryptococcosis.
  • B cells, natural IgM, and Fc gamma receptor polymorphisms are important factors in host defense against Cryptococcus.
  • Further research into these areas may lead to improved therapeutic strategies.